Literature DB >> 22068612

NFκB and HIF display synergistic behaviour during hypoxic inflammation.

Ulrike Bruning1, Susan F Fitzpatrick, Till Frank, Marc Birtwistle, Cormac T Taylor, Alex Cheong.   

Abstract

The oxygen-sensitive transcription factor hypoxia inducible factor (HIF) is a key regulator of gene expression during adaptation to hypoxia. Crucially, inflamed tissue often displays regions of prominent hypoxia. Recent studies have shown HIF signalling is intricately linked to that of the pro-inflammatory transcription factor nuclear factor kappa B (NFκB) during hypoxic inflammation. We describe the relative temporal contributions of each to hypoxia-induced inflammatory gene expression and investigate the level of crosstalk between the two pathways using a novel Gaussia princeps luciferase (Gluc) reporter system. Under the control of an active promoter, Gluc is expressed and secreted into the cell culture media, where it can be sampled and measured over time. Thus, Gluc constructs under the control of either HIF or NFκB were used to resolve their temporal transcriptional dynamics in response to hypoxia and to cytokine stimuli, respectively. We also investigated the interactions between HIF and NFκB activities using a construct containing the sequence from the promoter of the inflammatory gene cyclooxygenase 2 (COX-2), which includes functionally active binding sites for both HIF and NFκB. Finally, based on our experimental data, we constructed a mathematical model of the binding affinities of HIF and NFκB to their respective response elements to analyse transcriptional crosstalk. Taken together, these data reveal distinct temporal HIF and NFκB transcriptional activities in response to hypoxic inflammation. Furthermore, we demonstrate synergistic activity between these two transcription factors on the regulation of the COX-2 promoter, implicating a co-ordinated role for both HIF and NFκB in the expression of COX-2 in hypoxic inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22068612     DOI: 10.1007/s00018-011-0876-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  43 in total

1.  Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.

Authors:  Eoin P Cummins; Edurne Berra; Katrina M Comerford; Amandine Ginouves; Kathleen T Fitzgerald; Fergal Seeballuck; Catherine Godson; Jens E Nielsen; Paul Moynagh; Jacques Pouyssegur; Cormac T Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

Review 2.  Transcriptional regulation via the NF-kappaB signaling module.

Authors:  A Hoffmann; G Natoli; G Ghosh
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

Review 3.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

4.  The OR control system of bacteriophage lambda. A physical-chemical model for gene regulation.

Authors:  M A Shea; G K Ackers
Journal:  J Mol Biol       Date:  1985-01-20       Impact factor: 5.469

5.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  An intact canonical NF-κB pathway is required for inflammatory gene expression in response to hypoxia.

Authors:  Susan F Fitzpatrick; Murtaza M Tambuwala; Ulrike Bruning; Bettina Schaible; Carsten C Scholz; Annette Byrne; Aisling O'Connor; William M Gallagher; Colin R Lenihan; John F Garvey; Katherine Howell; Padraic G Fallon; Eoin P Cummins; Cormac T Taylor
Journal:  J Immunol       Date:  2010-12-13       Impact factor: 5.422

7.  Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells.

Authors:  J F Schmedtje; Y S Ji; W L Liu; R N DuBois; M S Runge
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

8.  Activators of protein kinase C selectively mediate cellular cytotoxicity to hypoxic cells and not aerobic cells.

Authors:  A C Koong; E Y Chen; C Y Kim; A J Giaccia
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-05-15       Impact factor: 7.038

9.  Regulation of vascularization by hypoxia-inducible factor 1.

Authors:  Gregg L Semenza
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

10.  Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).

Authors:  Matthew E Cockman; David E Lancaster; Ineke P Stolze; Kirsty S Hewitson; Michael A McDonough; Mathew L Coleman; Charlotte H Coles; Xiaohong Yu; Ronald T Hay; Steven C Ley; Christopher W Pugh; Neil J Oldham; Norma Masson; Christopher J Schofield; Peter J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

View more
  30 in total

Review 1.  Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.

Authors:  Elise Belaidi; Jessica Morand; Emmanuelle Gras; Jean-Louis Pépin; Diane Godin-Ribuot
Journal:  Pharmacol Ther       Date:  2016-08-02       Impact factor: 12.310

Review 2.  HIF-1 at the crossroads of hypoxia, inflammation, and cancer.

Authors:  Kuppusamy Balamurugan
Journal:  Int J Cancer       Date:  2015-04-07       Impact factor: 7.396

3.  Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

Authors:  Shiro Mizuno; Laszlo Farkas; Aysar Al Husseini; Daniela Farkas; Jose Gomez-Arroyo; Donatas Kraskauskas; Mark R Nicolls; Carlyne D Cool; Herman J Bogaard; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2012-07-27       Impact factor: 6.914

Review 4.  Hypoxia-dependent regulation of inflammatory pathways in immune cells.

Authors:  Cormac T Taylor; Glen Doherty; Padraic G Fallon; Eoin P Cummins
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

5.  Cross Talk in HEK293 Cells Between Nrf2, HIF, and NF-κB Activities upon Challenges with Redox Therapeutics Characterized with Single-Cell Resolution.

Authors:  Katarina Johansson; Marcus Cebula; Olle Rengby; Kristian Dreij; Karl E Carlström; Kristmundur Sigmundsson; Fredrik Piehl; Elias S J Arnér
Journal:  Antioxid Redox Signal       Date:  2015-11-11       Impact factor: 8.401

Review 6.  Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis.

Authors:  Ursula Fearon; Mary Canavan; Monika Biniecka; Douglas J Veale
Journal:  Nat Rev Rheumatol       Date:  2016-05-26       Impact factor: 20.543

7.  Hypercapnia Suppresses the HIF-dependent Adaptive Response to Hypoxia.

Authors:  Andrew C Selfridge; Miguel A S Cavadas; Carsten C Scholz; Eric L Campbell; Lynn C Welch; Emilia Lecuona; Sean P Colgan; Kim E Barrett; Peter H S Sporn; Jacob I Sznajder; Eoin P Cummins; Cormac T Taylor
Journal:  J Biol Chem       Date:  2016-04-04       Impact factor: 5.157

8.  Consequences of Hypoxia for the Pulmonary Alveolar Epithelial Cell Innate Immune Response.

Authors:  Anne Sturrock; Diana Woller; Andrew Freeman; Karl Sanders; Robert Paine
Journal:  J Immunol       Date:  2018-10-31       Impact factor: 5.422

9.  Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF.

Authors:  Jonathan A Wheeler; Erica L Clinkenbeard
Journal:  Curr Mol Biol Rep       Date:  2019-01-25

10.  Hypoxia-inducible factor (HIF) network: insights from mathematical models.

Authors:  Miguel As Cavadas; Lan K Nguyen; Alex Cheong
Journal:  Cell Commun Signal       Date:  2013-06-10       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.